1. The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma
   Angkana Thongkum et al, 2017, IJMS CrossRef
2. Potential therapeutic targets for growth arrest of colorectal cancer cells exposed to PTHrP
   María Julia Martín et al, 2018, Molecular and Cellular Endocrinology CrossRef
3. Argininosuccinate synthetase gene is silenced by CpG methylation in children with phenylketonuria
   Li Li et al, 2013, Clinical Biochemistry CrossRef
4. Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma.
   Qingqing Liu et al, 0 CrossRef
5. Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI‑PEG20 treatment in CCA cell lines
   Somphon Roeksomtawin et al, 2018, Oncol Lett CrossRef
6. Intracellular Delivery of Recombinant Arginine Deiminase (rADI) by Heparin-Binding Hemagglutinin Adhesion Peptide Restores Sensitivity in rADI-Resistant Cancer Cells
   Fe-Lin Lin Wu et al, 2014, Mol. Pharmaceutics CrossRef
7. Treating liver cancer through arginine depletion
   Yenisetti Rajendra Prasad et al, 2024, Drug Discovery Today CrossRef